Nasic (Xylometazoline Hydrochloride, Dexpanthenol)

Xylometazoline Hydrochloride, the active ingredient in Nasic, is a alpha‑adrenergic agonist presented as a nasal spray for nasal use. It treats nasal congestion associated with the common cold, sinusitis and allergic rhinitis. Dexpanthenol, a mucosal protectant, supports epithelial repair and moisturisation.

GNH USA supplies Nasic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nasic, containing an alpha‑adrenergic nasal decongestant and a mucosal protectant, relieves nasal obstruction in several upper‑respiratory conditions. - Common cold: reduces nasal congestion and improves airflow. - Sinusitis: alleviates blockage of the nasal passages associated with sinus inflammation. - Allergic rhinitis: decreases swelling of nasal mucosa caused by allergen exposure.

Nasic may cause local or systemic adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal burning or stinging. - Mild dryness of the nasal mucosa. - Sneezing. - Transient taste disturbance.

Serious or Rare Side Effects: - Persistent nasal irritation or ulceration. - Severe hypertension. - Allergic reaction with rash or swelling. - Nasal septum perforation (very rare).

Before using Nasic, consider the following precautions to ensure safe and effective treatment. - Age restriction: not recommended for children under 2 years without medical advice. - Cardiovascular disease: use cautiously in patients with hypertension or heart disease. - Recent nasal surgery: avoid immediate use after nasal procedures. - Concomitant monoamine oxidase inhibitors: consult a physician before combining. - Prolonged use: limit to three consecutive days to prevent rebound congestion. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nasic can interact with other medicines; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive episodes. - Systemic decongestants (e.g., pseudoephedrine): additive vasoconstrictive effect can raise blood pressure.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: nasal vasoconstriction may reduce efficacy of blood pressure medications. - Beta‑blockers: possible enhancement of vasoconstrictive response. - Nasal corticosteroids: monitor for increased local irritation.